KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sarepta Therapeutics (SRPT) Operating Income (2016 - 2025)

Sarepta Therapeutics has reported Operating Income over the past 15 years, most recently at -$411.6 million for Q4 2025.

  • Quarterly results put Operating Income at -$411.6 million for Q4 2025, down 354.56% from a year ago — trailing twelve months through Dec 2025 was -$699.8 million (down 420.88% YoY), and the annual figure for FY2025 was -$699.8 million, down 420.88%.
  • Operating Income for Q4 2025 was -$411.6 million at Sarepta Therapeutics, down from -$103.4 million in the prior quarter.
  • Over the last five years, Operating Income for SRPT hit a ceiling of $161.7 million in Q4 2024 and a floor of -$411.6 million in Q4 2025.
  • Median Operating Income over the past 5 years was -$104.6 million (2021), compared with a mean of -$87.3 million.
  • Peak annual rise in Operating Income hit 16587.45% in 2025, while the deepest fall reached 960.58% in 2025.
  • Sarepta Therapeutics' Operating Income stood at -$105.8 million in 2021, then decreased by 0.96% to -$106.8 million in 2022, then skyrocketed by 123.05% to $24.6 million in 2023, then surged by 556.57% to $161.7 million in 2024, then crashed by 354.56% to -$411.6 million in 2025.
  • The last three reported values for Operating Income were -$411.6 million (Q4 2025), -$103.4 million (Q3 2025), and $115.6 million (Q2 2025) per Business Quant data.